88 related articles for article (PubMed ID: 3924666)
1. Concentration-dependent mechanisms of ovulation inhibition by the progestin ST-1435.
Lähteenmäki PL; Lähteenmäki P
Fertil Steril; 1985 Jul; 44(1):20-4. PubMed ID: 3924666
[TBL] [Abstract][Full Text] [Related]
2. Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST-1435.
Lähteenmäki P; Weiner E; Lähteenmäki P; Johansson ED; Luukkainen T
Contraception; 1982 Mar; 25(3):299-306. PubMed ID: 6804165
[TBL] [Abstract][Full Text] [Related]
3. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
4. Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435.
Lähteenmäki P; Weiner E; Lähteenmäki P; Johansson E; Luukkainen T
Contraception; 1981 Jan; 23(1):63-75. PubMed ID: 7471746
[TBL] [Abstract][Full Text] [Related]
5. Intracervical release of ST-1435 for contraception.
Kurunmäki H; Toivonen J; Lähteenmäki PL; Luukkainen T
Contraception; 1984 May; 29(5):411-21. PubMed ID: 6430641
[TBL] [Abstract][Full Text] [Related]
6. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
7. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
[TBL] [Abstract][Full Text] [Related]
8. Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study.
Haukkamaa M; Laurikka-Routti M; Heikinheimo O; Moo-Young A
Contraception; 1992 Jan; 45(1):49-55. PubMed ID: 1591921
[TBL] [Abstract][Full Text] [Related]
9. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
10. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
11. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
12. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
Richardson DW; Gordon K; Billiar RB; Little AB
Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the positive feedback of oestradiol during treatment with subcutaneous implants of d-norgestrel.
Weiner E; Johansson ED; Wide L
Contraception; 1976 Mar; 13(3):287-98. PubMed ID: 1248256
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
15. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ovulation by a new low-dose monophasic contraceptive containing gestodene.
Thomas KH; Vankrieken L
Int J Fertil; 1989 Sep; 34 Suppl():10-21. PubMed ID: 2576249
[TBL] [Abstract][Full Text] [Related]
17. Roles of estradiol and progesterone in eiliciting the midcycle luteinizing hormone and follicle-stimulating hormone surges.
March CM; Goebelsmann U; Nakamura RM; Mishell DR
J Clin Endocrinol Metab; 1979 Oct; 49(4):507-13. PubMed ID: 479343
[TBL] [Abstract][Full Text] [Related]
18. 2,3,7,8-tetrachlorodibenzo-p-dioxin decreases responsiveness of the hypothalamus to estradiol as a feedback inducer of preovulatory gonadotropin secretion in the immature gonadotropin-primed rat.
Gao X; Mizuyachi K; Terranova PF; Rozman KK
Toxicol Appl Pharmacol; 2001 Feb; 170(3):181-90. PubMed ID: 11162783
[TBL] [Abstract][Full Text] [Related]
19. Antiovulatory activity of synthetic corticoids.
Cunningham GR; Caperton EM; Goldzieher JW
J Clin Endocrinol Metab; 1975 Feb; 40(2):265-7. PubMed ID: 1117979
[TBL] [Abstract][Full Text] [Related]
20. Periovulatory hormonal dynamics: relationship of immunoassayable gonadotropins and ovarian steroids to the bioassayable luteinizing hormone surge in rhesus monkeys.
Schenken RS; Werlin LB; Williams RF; Prihoda TJ; Hodgen GD
J Clin Endocrinol Metab; 1985 May; 60(5):886-90. PubMed ID: 3920234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
